{"id":"NCT00950651","sponsor":"Labopharm Inc.","briefTitle":"A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol HCl / Contramid® Tablets to Twice Daily Tramadol HCl (SR) for the Treatment of Osteoarthritis of the Knee","officialTitle":"A Comparison of the Analgesic Efficacy and Safety of Once Daily Tramadol HCl / Contramid® Tablets to Twice Daily Tramadol HCl (SR) for the Treatment of Osteoarthritis of the Knee.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-03","primaryCompletion":"2002-11","completion":"2002-11","firstPosted":"2009-08-03","resultsPosted":"2009-08-03","lastUpdate":"2012-04-30"},"enrollment":431,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis, Knee","Pain"],"interventions":[{"type":"DRUG","name":"Tramadol HCl Contramid® Once A Day","otherNames":[]},{"type":"DRUG","name":"Tramadol HCl Twice a day","otherNames":[]}],"arms":[{"label":"1 Tramadol HCl Contramid® Once A Day","type":"EXPERIMENTAL"},{"label":"2 Tramadol HCl Twice a day (SR)","type":"ACTIVE_COMPARATOR"}],"summary":"A randomised, multi-centre, double-blind, double dummy, two arm parallel design study to compare the efficacy, safety, and clinical benefit of the test and reference product after treatment for 84 days in patients with osteoarthritis of the knee.","primaryOutcome":{"measure":"Percentage of Change From Baseline in WOMAC Pain Subscale Score at Week 12","timeFrame":"Baseline to week 12","effectByArm":[{"arm":"Tramadol HCl Contramid® Once A Day","deltaMin":58.3,"sd":29.9},{"arm":"Tramadol HCl Twice a Day (SR)","deltaMin":58.7,"sd":27}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["17523716"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":215},"commonTop":["Nausea","Constipation","Dizziness","Somnolence","Headache"]}}